This post is from guest author Seth Whitelaw with the Whitelaw Compliance Group. You may follow Seth on LinkedIn here. 

Recently, the Justice Department targeted three companies in the pharmaceutical and medical device industry (Rochester Drug Co-Operative, Indivior, and Life Spine) as it aims to stamp out health care fraud. They are a clear signal that the DOJ is serious when it comes to effective compliance.